Biodesix, Inc.
NASDAQ:BDSX
1.39 (USD) • At close November 4, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q2 | 2018 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 18.151 | 17.925 | 14.818 | 14.668 | 13.491 | 11.872 | 9.056 | 9.608 | 11.107 | 10.95 | 6.548 | 7.224 | 6.531 | 11.885 | 28.866 | 27.028 | 9.193 | 4.239 | 5.096 | 8.271 | 3.942 | 6.17 | 6.17 | 5.108 | 5.108 |
| Cost of Revenue
| 4.179 | 3.877 | 3.175 | 3.374 | 3.229 | 3.238 | 3.169 | 3.306 | 3.633 | 3.98 | 3.235 | 2.493 | 2.722 | 7.085 | 18.218 | 14.652 | 3.891 | 1.874 | 1.581 | 1.83 | 1.503 | 1.371 | 1.371 | 1.102 | 1.102 |
| Gross Profit
| 13.972 | 14.048 | 11.643 | 11.294 | 10.262 | 8.634 | 5.887 | 6.302 | 7.474 | 6.97 | 3.313 | 4.731 | 3.809 | 4.8 | 10.648 | 12.376 | 5.302 | 2.365 | 3.515 | 6.441 | 2.439 | 4.799 | 4.799 | 4.007 | 4.007 |
| Gross Profit Ratio
| 0.77 | 0.784 | 0.786 | 0.77 | 0.761 | 0.727 | 0.65 | 0.656 | 0.673 | 0.637 | 0.506 | 0.655 | 0.583 | 0.404 | 0.369 | 0.458 | 0.577 | 0.558 | 0.69 | 0.779 | 0.619 | 0.778 | 0.778 | 0.784 | 0.784 |
| Reseach & Development Expenses
| 2.547 | 2.558 | 2.04 | 1.889 | 1.938 | 2.91 | 3.251 | 3.565 | 2.97 | 3.361 | 3.206 | 2.852 | 3.293 | 3.323 | 3.321 | 3.105 | 2.706 | 2.107 | 2.9 | 2.502 | 2.359 | 2.804 | 2.804 | 2.047 | 2.047 |
| General & Administrative Expenses
| 0 | 0 | 0 | 35.24 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 26.978 | 7.879 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | -18.989 | 0 | 0 | 18.989 | 16.626 | 15.114 | 15.235 | 14.487 | 13.558 | 13.607 | 11.425 | 11.927 | 12.064 | 7.879 | 6.834 | 8.08 | 6.557 | 8.212 | 0 | 0 | 6.475 | 6.475 |
| SG&A
| 20.016 | 19.66 | 20.556 | 16.251 | 15.496 | 16.651 | 18.989 | 16.626 | 15.114 | 15.235 | 14.487 | 13.558 | 13.607 | 11.425 | 11.927 | 12.064 | 7.879 | 6.834 | 8.08 | 6.557 | 8.212 | 7.934 | 7.934 | 6.475 | 6.475 |
| Other Expenses
| 4.179 | -0.387 | -0.064 | 0.002 | 0.002 | 0.001 | 0.001 | -0.005 | 0.002 | 0.1 | 0.012 | -0.01 | 2.722 | -0.639 | 0.001 | 0.036 | -0.904 | 0.133 | 0.123 | -0.855 | -0.763 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 26.742 | 22.218 | 22.596 | 18.14 | 17.434 | 19.561 | 22.24 | 20.191 | 18.084 | 18.596 | 17.693 | 16.41 | 16.9 | 14.748 | 15.248 | 15.169 | 10.585 | 8.941 | 10.98 | 9.059 | 10.571 | 11.449 | 11.449 | 8.522 | 8.522 |
| Operating Income
| -8.591 | -8.17 | -10.953 | -6.846 | -7.172 | -10.927 | -16.353 | -13.889 | -10.61 | -11.626 | -14.38 | -11.679 | -13.091 | -10.587 | -5.583 | -2.655 | -6.24 | -5.619 | -8.422 | -3.544 | -9.028 | -5.939 | -5.939 | -4.515 | -4.515 |
| Operating Income Ratio
| -0.473 | -0.456 | -0.739 | -0.467 | -0.532 | -0.92 | -1.806 | -1.446 | -0.955 | -1.062 | -2.196 | -1.617 | -2.004 | -0.891 | -0.193 | -0.098 | -0.679 | -1.326 | -1.653 | -0.428 | -2.29 | -0.963 | -0.963 | -0.884 | -0.884 |
| Total Other Income Expenses Net
| -1.667 | -2.638 | -2.661 | -2.293 | -1.391 | 0.001 | -2.349 | -6.448 | -3.089 | -2.852 | -1.206 | -0.107 | 3.123 | -0.639 | -1.71 | -1.046 | -0.904 | 1.094 | -0.783 | -2.959 | -0.763 | -1.361 | -1.361 | -2.026 | -2.026 |
| Income Before Tax
| -10.258 | -10.808 | -13.614 | -9.139 | -10.949 | -13.356 | -18.702 | -20.337 | -13.699 | -15.824 | -15.586 | -13.282 | -11.514 | -11.402 | -6.961 | -4.535 | -8.845 | -8.266 | -9.705 | -6.525 | -9.601 | -7.3 | -7.3 | -6.542 | -6.542 |
| Income Before Tax Ratio
| -0.565 | -0.603 | -0.919 | -0.623 | -0.812 | -1.125 | -2.065 | -2.117 | -1.233 | -1.445 | -2.38 | -1.839 | -1.763 | -0.959 | -0.241 | -0.168 | -0.962 | -1.95 | -1.904 | -0.789 | -2.436 | -1.183 | -1.183 | -1.281 | -1.281 |
| Income Tax Expense
| -1.417 | 0 | 1.279 | -3.231 | 2.386 | 2.431 | -1.586 | 6.449 | 3.089 | 1.446 | 1.206 | -7.52 | 1.546 | 0.815 | 0.652 | 0.012 | 1.754 | 2.917 | 1.58 | 0.148 | -0.057 | 0 | 0 | -1.297 | -1.297 |
| Net Income
| -10.258 | -10.808 | -13.614 | -9.139 | -10.949 | -13.356 | -17.116 | -26.786 | -16.788 | -15.824 | -16.792 | -13.282 | -11.514 | -11.402 | -6.961 | -4.535 | -8.845 | -8.266 | -9.705 | -6.525 | -9.601 | -7.3 | -7.3 | -6.542 | -6.542 |
| Net Income Ratio
| -0.565 | -0.603 | -0.919 | -0.623 | -0.812 | -1.125 | -1.89 | -2.788 | -1.511 | -1.445 | -2.564 | -1.839 | -1.763 | -0.959 | -0.241 | -0.168 | -0.962 | -1.95 | -1.904 | -0.789 | -2.436 | -1.183 | -1.183 | -1.281 | -1.281 |
| EPS
| -0.07 | -0.085 | -0.14 | -0.099 | -0.14 | -0.17 | -0.22 | -0.46 | -0.42 | -0.4 | -0.54 | -0.49 | -0.41 | -0.41 | -0.26 | -0.17 | -0.33 | -0.31 | -0.37 | -0.25 | -0.362 | -0.32 | -0.32 | -0.25 | -0.25 |
| EPS Diluted
| -0.07 | -0.085 | -0.14 | -0.099 | -0.14 | -0.17 | -0.22 | -0.46 | -0.42 | -0.4 | -0.54 | -0.49 | -0.41 | -0.41 | -0.26 | -0.17 | -0.33 | -0.31 | -0.37 | -0.25 | -0.362 | -0.32 | -0.32 | -0.25 | -0.25 |
| EBITDA
| -8.591 | -6.851 | -9.631 | -5.541 | -7.17 | -9.508 | -16.352 | -13.894 | -8.944 | -10.18 | -13.18 | -11.689 | -12.291 | -9.171 | -3.853 | -2.748 | -5.404 | -5.73 | -6.664 | -2.705 | -8.197 | -5.248 | -5.248 | -5.378 | -5.378 |
| EBITDA Ratio
| -0.473 | -0.382 | -0.65 | -0.378 | -0.531 | -0.801 | -1.806 | -1.446 | -0.805 | -0.93 | -2.013 | -1.618 | -1.882 | -0.772 | -0.133 | -0.102 | -0.588 | -1.352 | -1.308 | -0.327 | -2.079 | -0.851 | -0.851 | -1.053 | -1.053 |